Skip to main content
Premium Trial:

Request an Annual Quote

Orchid to Implement One-for-five Reverse Stock Split by End of Month

NEW YORK, March 25 (GenomeWeb News) - Orchid BioSciences will implement a one-for-five reverse stock split, effective March 30, the company said today.


Each five shares of Orchid's common stock will be converted into one share, resulting in approximately 22.1 million shares of common stock. Orchid's board of directors recently authorized the reverse split, which was approved by stockholders last month.


The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.